Olumiant Olumiant [Member] Olumiant [Member] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] 2026 Defined Benefit Plan, Expected Future Benefit Payment, Year Two Prepaid taxes Prepaid Taxes Adjustments to Reconcile Net Income to Cash Flows from Operating Activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Repayments of long-term debt Repayments of Long-Term Debt Estimated amortization expense Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract] Income tax at the U.S. federal statutory tax rate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount Cover [Abstract] Cover [Abstract] Neuroscience Neuroscience [Member] Revenue to unaffiliated customers, Neuroscience After 2029 Lessee, Operating Lease, Liability, to be Paid, after Year Five Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Acquired IPR&D In Process Research and Development [Member] 7.125% notes due 2025 7.125% Notes Due 2025 [Member] 7.125% Notes Due 2025 Schedule of Maturities of Operating Lease Liabilities Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Intangible Asset, Indefinite-Lived [Table] Intangible Asset, Indefinite-Lived [Table] Income Tax Jurisdiction [Domain] Income Tax Jurisdiction [Domain] Effect from hedged fixed-rate debt Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge Trading Symbol Trading Symbol Fair value hedges Fair Value Hedging [Member] Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Axis] Amortization of retirement benefit items Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member] Non-NEOs Non-NEOs [Member] Tax benefit Share-Based Payment Arrangement, Expense, Tax Benefit Revenue, information used to determine revenue recognized, change in accounting estimate, percent (or less) Revenue, Information Used To Determine Revenue Recognized, Change In Accounting Estimate, Percent Revenue, Information Used To Determine Revenue Recognized, Change In Accounting Estimate, Percent Cash dividend declared per share (in usd per share) Common Stock, Dividends, Per Share, Declared 1.375% Notes due 2061 1.375% euro denominated notes due 2061 1.375% Euro Denominated Notes Due 2061 [Member] 1.375% Euro Denominated Notes Due 2061 2027 Defined Benefit Plan, Expected Future Benefit Payment, Year Three Accounts receivable, allowances Accounts Receivable, Allowance for Credit Loss, Current Disposal Group Name [Domain] Disposal Group Name [Domain] Additional Segment Information Segment Reporting Information, Additional Information [Abstract] Debt Instrument, Redemption, Period [Domain] Debt Instrument, Redemption, Period [Domain] Net investment losses on equity securities Net investment losses on equity securities (Note 7) Equity Securities, FV-NI, Gain (Loss) Earnings Per Share (EPS) Earnings Per Share, Policy [Policy Text Block] Summary of Significant Accounting Policies and Implementation of New Financial Accounting Standards Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Marketable equity securities Marketable Securities [Member] Marketable Securities [Member] Inventories Inventory, Policy [Policy Text Block] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Hedging Relationship [Domain] Hedging Relationship [Domain] Financial Instruments Fair Value Disclosures [Text Block] Award Timing Disclosures [Line Items] Net investment hedges Net Investment Hedging [Member] Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Gains on sale of product rights Gain (Loss) on Disposition of Intangible Assets Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] 5.050% notes due 2054 5.05% Notes Due 2054 [Member] 5.05% Notes Due 2054 Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Tax credit carryforwards Deferred Tax Assets, Tax Credit Carryforwards Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] U.S. UNITED STATES Other noncurrent assets Other Assets, Noncurrent Leases [Abstract] Leases [Abstract] Carrying Amount, Gross Finite-Lived Intangible Assets, Gross Deferred: Deferred Federal, State and Local, Tax Expense (Benefit) [Abstract] Foreign-derived intangible income deduction Effective Income Tax Rate Reconciliation, FDII, Amount Net Cash Provided by Operating Activities Net Cash Provided by (Used in) Operating Activities Cash Flows from Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Deferred tax assets related to state net operating losses Deferred Tax Assets, Operating Loss Carryforwards, State and Local Other Stockholders' Equity, Other Prepaid expenses Prepaid Expense, Current Award Timing Method Award Timing Method [Text Block] Net periodic (benefit) cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Designated Unusable Designated Unusable [Member] Those operating loss/tax credit carryforwards/carrybacks included that have been designated to be unusable and therefore, is fully reserved. Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Fair value adjustment on hedged long-term notes Long-term Debt, Fair Value Adjustment Fair value adjustment to carrying value of long term debt to arrive at total fair value. Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Insider Trading Policies and Procedures [Line Items] Fair value of plan assets Fair value of plan assets Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Plan Assets Adjustment to Compensation, Amount Adjustment to Compensation Amount Additional paid-in capital Additional Paid in Capital, Common Stock Compensation Amount Outstanding Recovery Compensation Amount Unfunded commitments to invest in venture capital funds, anticipated payment period Fair Value, Investments, Entities That Calculate Net Asset Value Per Share, Unfunded Commitments, Payment Period Fair Value, Investments, Entities That Calculate Net Asset Value Per Share, Unfunded Commitments, Payment Period Disposal Group Classification [Axis] Disposal Group Classification [Axis] Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] 4.200% notes due 2029 4.2% Notes Due 2029 [Member] 4.2% Notes Due 2029 Entity Small Business Entity Small Business Company Selected Measure Amount Company Selected Measure Amount 4.750% Notes Due 2030 4.750% Notes Due in 2030 [Member] 4.750% Notes Due in 2030 Tabular List, Table Tabular List [Table Text Block] Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Expected return on plan assets Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Expected Long-Term Rate of Return on Plan Assets Stock-based compensation Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount Revenue, performance obligation, sales returns, percentage of net revenue (less than) Revenue, Performance Obligation, Sales Returns, Percentage Of Net Revenue Revenue, Performance Obligation, Sales Returns, Percentage Of Net Revenue No Expiration No Expiration [Member] Those operating loss/tax credit carryforwards/carrybacks included that have no expiration. 5.500% Notes Due 2055 5.500% Notes Due in 2055 [Member] 5.500% Notes Due in 2055 LIFO inventory amount LIFO Inventory Amount Trulicity Trulicity [Member] Trulicity Intangibles Deferred Tax Liabilities, Goodwill and Intangible Assets Asset Acquisition [Axis] Asset Acquisition [Axis] Goodwill (Note 8) Goodwill Goodwill Potential achievements Collaborative Arrangement, Rights and Obligations, Rights (Obligations) Collaborative Arrangement, Rights And Obligations, Rights (Obligations) Ebglyss Ebglyss [Member] Ebglyss Stock repurchase program, authorized amount Share Repurchase Program, Authorized, Amount Schedule of Changes in Accumulated Postemployment Benefit Obligations Schedule of Changes in Accumulated Postemployment Benefit Obligations [Table Text Block] Inventories Inventory Disclosure [Text Block] Basaglar® Basaglar Basaglar [Member] Basaglar [Member] Developed markets Fixed Income Funds [Member] Employee Stock Option Share-Based Payment Arrangement, Option [Member] Current: Current Federal, State and Local, Tax Expense (Benefit) [Abstract] Depreciation expense Depreciation Chugai Chugai [Member] Chugai Less: Less Significant Expenses [Abstract] Less Significant Expenses 2025 Lessee, Operating Lease, Liability, to be Paid, Year One Other financing activities, net Proceeds from (Payments for) Other Financing Activities Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Defined Benefit Pension Plans Pension Plan [Member] Real estate Employee Benefit Plan, Real Estate [Member] Senior Notes Due 2027, 2029, 2034, 2054 And 2064 Senior Notes Due 2027, 2029, 2034, 2054 And 2064 [Member] Senior Notes Due 2027, 2029, 2034, 2054 And 2064 Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration] Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration] Summary of the Contractual Maturities of Our Investments in Debt Securities Measured at Fair Value Investments Classified by Contractual Maturity Date [Table Text Block] Award Type [Axis] Award Type [Axis] Corporate debt securities Corporate Debt Securities [Member] Total (approximates replacement cost) Inventory, Gross Property and equipment, net (Note 9) Property and equipment, net Property, Plant and Equipment, Net ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Noncontrolling interests Equity, Attributable to Noncontrolling Interest Long-lived assets Long-Lived Assets Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Foreign Currency Translation Foreign Currency Transactions and Translations Policy [Policy Text Block] Expiration Date Trading Arrangement Expiration Date Cash Flows from Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Operating lease liabilities, current portion Operating Lease, Liability, Current Total Shareholder Return Amount Total Shareholder Return Amount Revenue, performance obligation, payment terms, financing component, period between transfer of control and payment receipt (or less) Revenue, Performance Obligation, Payment Terms, Financing Component, Period Between Transfer Of Control And Payment Receipt Revenue, Performance Obligation, Payment Terms, Financing Component, Period Between Transfer Of Control And Payment Receipt More Than 10 Years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] 4.500% notes due 2027 4.5% Notes Due 2027 [Member] 4.5% Notes Due 2027 Tax loss and other tax carryforwards Deferred Tax Assets, Operating Loss Carryforwards Taltz Taltz [Member] Taltz [Member] Equipment Equipment [Member] Property and equipment, gross Property, Plant and Equipment, Gross Effective portion of risk-management instruments that was recognized in other comprehensive income (loss) Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax 4.150% notes due 2027 4.15% Notes Due 2027 [Member] 4.15% Notes Due 2027 Debt Instrument [Line Items] Debt Instrument [Line Items] Debt Instrument [Line Items] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Goodwill and Intangible Assets Goodwill and Intangible Assets, Policy [Policy Text Block] Lapses of statutes of limitation Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 3.95% notes due 2049 3.95% Notes Due 2049 [Member] 3.95% Notes Due 2049 [Member] 4.600% notes due 2034 A4.5% Notes Due 2034 [Member] A4.5% Notes Due 2034 Verzenio Verzenio [Member] Verzenio [Member] 4.15% notes due 2059 4.15% Notes Due 2059 [Member] 4.15% Notes Due 2059 [Member] Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Total Eli Lilly and Company shareholders' equity Beginning balance Ending balance Equity, Attributable to Parent Total gross deferred tax assets Deferred Tax Assets, Gross Proceeds from issuance of debt Proceeds from Issuance of Debt Collaborations and Other Arrangements Collaborative Arrangement Disclosure [Text Block] Less Than 1 Year Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Litigation Case [Axis] Litigation Case [Axis] Construction in progress Construction in Progress, Gross Revenue recognized Disposal Group, Including Discontinued Operation, Revenue 5.95% notes due 2037 5.95% Notes Due 2037 [Member] 5.95% Notes Due 2037 Other receivables Derivative Asset, Current Concentration Risk Type [Domain] Concentration Risk Type [Domain] Marketing, selling, and administrative Selling, General and Administrative Expense Defined Benefit Plan, Pension Plan with Project Benefit Obligation in Excess of Plan Assets [Abstract] Defined Benefit Plan, Pension Plan with Project Benefit Obligation in Excess of Plan Assets [Abstract] Expense under the plans Defined Contribution Plan, Cost Proceeds from sales of and distributions from noncurrent investments Proceeds from Sale and Maturity of Other Investments Net product revenue Product [Member] Biopharma Global Inc Point Biopharma Global Inc [Member] Point Biopharma Global Inc Document Fiscal Period Focus Document Fiscal Period Focus Employee Litigation, July 2019 Ruling Employee Litigation, July 2019 Ruling [Member] Employee Litigation, July 2019 Ruling 2028 Long-Term Debt, Maturity, Year Four All Executive Categories All Executive Categories [Member] Sales returns, rebates, and discounts Sales Returns and Allowances [Member] Business acquisition, share price (in dollars per share) Business Acquisition, Share Price Net unrealized gains/losses on available-for-sale securities AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member] 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Two Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Assets Assets [Abstract] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Other oncology Other Oncology [Member] Other Oncology [Member] Non-deductible acquired IPR&D Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount Document Type Document Type Employee Litigation, July 2018 Ruling Employee Litigation, July 2018 Ruling [Member] Employee Litigation, July 2018 Ruling U.S. Defined Benefit Plan, Equity Securities, US [Member] Debt instrument, interest rate, effective percentage Debt Instrument, Interest Rate, Effective Percentage Derivative, Name [Domain] Derivative Contract [Domain] Actuarial (gain) loss Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Cash and cash equivalents at beginning of year Cash and Cash Equivalents at End of Year Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Hedged Fixed Rate Debt Hedged Fixed Rate Debt [Member] Hedged Fixed-Rate Debt [Member] Carryforward Carryforward [Member] Tax Carryforward [Member] Defined Benefit Plan [Table] Defined Benefit Plan [Table] Schedule of Amounts Recorded for Contract Liabilities Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Maximum Maximum [Member] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Carrying Amount, Net Finite-Lived Intangible Assets, Net Accounts payable Accounts Payable, Current Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Statistical Measurement [Axis] Statistical Measurement [Axis] Fair value hedges: Fair Value Hedge [Abstract] Fair Value Hedge [Abstract] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Income before income taxes Total before tax Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Property and equipment Deferred Tax Liabilities, Property, Plant and Equipment Name Outstanding Recovery, Individual Name Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Increase to LIFO cost Inventory, LIFO Reserve Goodwill, impairment loss Goodwill, Impairment Loss Acquisition date fair value of consideration transferred Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net General business credits Effective Income Tax Rate Reconciliation, Tax Credit, Amount Award Timing Predetermined Award Timing Predetermined [Flag] Unfavorable Regulatory Action Unfavorable Regulatory Action [Member] Subsequent Event Type [Domain] Subsequent Event Type [Domain] 5.0% notes due 2026 5.0% Notes Due 2026 [Member] 5.0% Notes Due 2026 Change in foreign currency translation gains (losses) Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax Amortization of prior service (benefit) cost Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Diluted (in dollars per share) Earnings Per Share, Diluted Defined Benefit Plan, Expected Future Benefit Payment [Abstract] Defined Benefit Plan, Expected Future Benefit Payment [Abstract] Schedule of finite-lived Intangible Assets Amortization Expense Finite-Lived Intangible Assets Amortization Expense [Table Text Block] State and Local Jurisdiction State and Local Jurisdiction [Member] Swap U.S Dollars To Euro Swap U.S. Dollars To Euro [Member] Swap U.S. Dollars To Euro Prior service benefits, net Accumulated Defined Benefit Plans Adjustment, Net Prior Service Including Portion Attributable to Noncontrolling Interest [Member] Total current tax expense Current Income Tax Expense (Benefit) Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Hedge funds Hedge Funds [Member] 7 1/8% Notes due 2025 7 1/8% Notes Due June 1, 2025 [Member] 7 1/8% Notes Due June 1, 2025 [Member] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Asset impairment, restructuring, and other special charges (Note 5) Asset impairment, restructuring, and other special charges Restructuring, Settlement and Impairment Provisions Shares issued (in shares) Preferred Stock, Shares Issued Customer [Axis] Customer [Axis] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Asset-backed securities Asset-Backed Securities [Member] Schedule of Additional Borrowings Disclosures Schedule of Additional Borrowings Disclosures [Table Text Block] Schedule of Additional Borrowings Disclosures [Table Text Block] Net income (loss) Total reclassifications for the period, net of tax Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Income taxes (Note 14) Income taxes Tax benefit Income taxes Income Tax Expense (Benefit) Interest cost Defined Benefit Plan, Interest Cost Nonoperating Income (Expense) [Abstract] Nonoperating Income (Expense) [Abstract] Short-term investments Debt Securities, Available-for-Sale, Current Immunology Immunology [Member] Immunology [Member] Components of net periodic (benefit) cost: Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract] Zepbound Zepbound [Member] Zepbound Period for recognition of the compensation cost not yet recognized Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Sell Chinese Yuan Sell Chinese Yuan [Member] Sell Chinese Yuan Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Net Cash Used for Investing Activities Net Cash Provided by (Used in) Investing Activities Income Tax Jurisdiction [Axis] Income Tax Jurisdiction [Axis] Business Acquisition [Line Items] Business Acquisition [Line Items] Versanis Bio, Inc. (Versanis) Versanis Bio, Inc [Member] Versanis Bio, Inc 1.625% euro denominated notes due 2026 1.625% Euro-denominated Notes Due 2026 [Member] 1.625% Euro-denominated Notes Due 2026 Other operating activities, net Other Operating Activities, Cash Flow Statement All Adjustments to Compensation All Adjustments to Compensation [Member] Employee compensation Employee-related Liabilities, Current Prepaid expenses and other assets—(increase) decrease Increase (Decrease) in Prepaid Expense and Other Assets Short-term Debt, Type [Domain] Short-Term Debt, Type [Domain] Schedule of Other Nonoperating Income (Expense) Schedule of Other Nonoperating Income (Expense) [Table Text Block] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Tax Credit Carryforward [Axis] Tax Credit Carryforward [Axis] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Legal Entity [Axis] Legal Entity [Axis] 5.100% Notes Due 2035 5.100% Notes Due in 2035 [Member] 5.100% Notes Due in 2035 Disposal Group, Disposed of by Sale, Not Discontinued Operations Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] Expiration By 2029 Expiration By 2029 [Member] Expiration By 2029 0.15% Swiss franc denominated notes due 2024 0.15% Swiss Franc-denominated Notes Due 2024 [Member] 0.15% Swiss Franc-denominated Notes Due 2024 Net unrealized gains/losses on cash flow hedges Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] U.S. government and agency securities US Government Agencies Debt Securities [Member] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Entity Address, State or Province Entity Address, State or Province Retirement benefit plans Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component Milestone payment received Disposal Group, Including Discontinued Operation, Milestone Payments To Be Received Disposal Group, Including Discontinued Operation, Milestone Payments To Be Received Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] 2.125% euro denominated notes due 2030 2.125% Euro-denominated Notes Due 2030 [Member] 2.125% Euro-denominated Notes Due 2030 Defined Benefit Plan, Plan Assets, Category [Domain] Defined Benefit Plan, Plan Assets, Category [Domain] Defined benefit obligation, period increase (decrease) Defined Benefit Plan, Benefit Obligation, Period Increase (Decrease) Consideration received Disposal Group, Including Discontinued Operation, Consideration Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Cost Portion at Other than Fair Value Measurement [Member] Amortization of prior service (benefit) cost included in net income Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax Financial Instruments [Domain] Financial Instruments [Domain] Liabilities and Equity Liabilities and Equity [Abstract] Offsetting Assets [Line Items] Offsetting Assets [Line Items] Schedule of Net Periodic (Benefit) Costs Schedule of Net Benefit Costs [Table Text Block] Proceeds from sales of available-for-sale investments Proceeds from Sale of Equity and Available for Sale Securities Proceeds from Sale of Equity and Available for Sale Securities 0.42% Japanese yen denominated notes due 2029 .42% Yen-denominated Notes Due 2029 [Member] .42% Yen-denominated Notes Due 2029 [Member] Restatement Determination Date Restatement Determination Date Collaborative arrangement, rights and obligations percent (up to) Collaborative Arrangement, Rights and Obligations Percent Description of rights and obligations under the collaborative arrangements, including but not limited to - percent share in various revenues and costs, percent interest earned on related party notes. Estimate of Fair Value Measurement Estimate of Fair Value Measurement [Member] Noncurrent investments Debt Securities, Available-for-Sale, Noncurrent Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Interest Rate Contract Interest Rate Contract [Member] Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] 4.875% notes due 2053 4.875% Notes Due 2053 [Member] 4.875% Notes Due 2053 Short-term Debt, Type [Axis] Short-Term Debt, Type [Axis] Summary of Fair Value Information, Liabilities Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Equity method investments Payments to Acquire Equity Method Investments Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Dividends payable Dividends Payable, Current Asset Impairment, Restructuring, And Other Special Charges Restructuring, Impairment, and Other Activities Disclosure [Text Block] Issuance of stock under employee stock plans, net Stock Issued During Period, Value, Employee Stock Purchase Plan Subsequent Event Subsequent Event [Member] Costs, expenses, and other: Costs and Expenses [Abstract] One Time Payment Received One Time Payment [Member] One Time Payment Weighted average grant date fair value (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Investment (gains) losses, net Gain (Loss) on Investments Income Taxes Income Tax, Policy [Policy Text Block] Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Segments [Domain] Segments [Domain] Other securities Other Debt Obligations [Member] Benefit (expense) for income taxes related to other comprehensive income (loss) Other Comprehensive Income (Loss), Tax Financial Information Regularly Reviewed by the CODM Segment Reporting Information, Profit (Loss) [Abstract] Unrecognized Tax Benefits [Roll Forward] Unrecognized Tax Benefits [Roll Forward] PEO PEO [Member] Name Trading Arrangement, Individual Name Funded status Defined Benefit Plan, Funded (Unfunded) Status of Plan Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Accumulated other comprehensive loss Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, before Tax Entity Public Float Entity Public Float Disposal Group Name [Axis] Disposal Group Name [Axis] 4.550% Notes Due 2028 4.550% Notes Due 2028 [Member] 4.550% Notes Due 2028 Remaining lease term (up to) Lessee, Operating Lease, Remaining Lease Term Earnings (loss) in equity method investments Income (Loss) from Equity Method Investments Cost of common stock in treasury Treasury Stock, Common, Value Benefit obligation at beginning of year Benefit obligation at end of year Defined Benefit Plan, Benefit Obligation 0.97% Japanese yen denominated notes due 2049 .97% Yen-denominated Notes Due 2049 [Member] .97% Yen-denominated Notes Due 2049 Acquired IPR&D Charge Payments for Asset Acquisitions Payments for Asset Acquisitions Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Revenue, performance obligation, payment terms, days from date of shipment, maximum Revenue from Contract, Payment Term, Maximum Revenue from Contract, Payment Term, Maximum Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] 3.875% notes due 2039 3.875% Notes Due 2039 [Member] Senior Notes Due 2039 [Member] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Domestic and Puerto Rican companies contribution Domestic and Puerto Rican Contribution to Income before Income Taxes Percent contribution of most significant (domestic, including Puerto Rico) areas that contributed to the consolidated income (loss) before income taxes. Local Phone Number Local Phone Number Carrying Amount, Gross Intangible Assets, Gross (Excluding Goodwill) Valuation allowances Deferred Tax Assets, Valuation Allowance Total debt Debt, Long-Term and Short-Term, Combined Amount Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Average remaining maturity of foreign currency derivatives Average Remaining Maturity of Foreign Currency Derivatives 0.625% Notes due 2031 .625% Notes due 2031 [Member] .625% Notes due 2031 [Member] Revenue, performance obligation, payment terms, days from date of shipment, minimum Revenue from Contract, Payment Term, Minimum Revenue from Contract, Payment Term Change in Accounting Estimate by Type [Axis] Change in Accounting Estimate by Type [Axis] Maximum remaining maturity of foreign currency derivatives Maximum Remaining Maturity of Foreign Currency Derivatives Other changes in operating assets and liabilities, net of acquisitions and divestitures: Increase (Decrease) in Operating Capital [Abstract] Noncurrent Liabilities Liabilities, Noncurrent [Abstract] PEO Total Compensation Amount PEO Total Compensation Amount Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Other comprehensive income (loss) before income taxes Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent Long-lived Assets by Geographic Areas Long-Lived Assets by Geographic Areas [Table Text Block] Defined Benefit Plan, Plan Assets, Category [Axis] Defined Benefit Plan, Plan Assets, Category [Axis] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Common Stock Common Stock [Member] Revenue, performance obligation, sales returns, product expiration date Revenue, Performance Obligation, Sales Returns, Product Expiration Date Revenue, Performance Obligation, Sales Returns, Product Expiration Date Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Accounts receivable derecognized Transfer of Financial Assets Accounted for as Sales, Amount Derecognized Segment Reporting [Abstract] Segment Reporting [Abstract] 1.125% Notes due 2051 1.125% euro denominated notes due 2051 1.125% Euro Denominated Notes Due 2051 [Member] 1.125% Euro Denominated Notes Due 2051 Entity Central Index Key Entity Central Index Key Other segment items Segment Reporting, Other Segment Item, Amount Schedule of Inventory Schedule of Inventory, Current [Table Text Block] Accruals for the payment of interest and penalties Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued DICE Therapeutics, Inc. (DICE) DICE Therapeutics, Inc [Member] DICE Therapeutics, Inc Foreign currency translation gains/losses Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Schedule of Equity [Line Items] Subsidiary or Equity Method Investee [Line Items] Shareholders' Equity Equity [Text Block] Accounts payable and other liabilities—increase (decrease) Increase (Decrease) in Accounts Payable and Accrued Liabilities Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Financial Instrument [Axis] Financial Instrument [Axis] Segment Information Segment Reporting Disclosure [Text Block] Schedule of Effects of Risk-Management Instruments Were Recognized in Other–Net, (Income) Expense Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block] Measurement Basis [Axis] Measurement Basis [Axis] Change in Accounting Estimate [Table] Change in Accounting Estimate [Table] 3.7% notes due 2045 3.7% Notes Due 2045 [Member] 3.7% Notes Due 2045 Intangible Assets, Net (Excluding Goodwill) [Abstract] Intangible Assets, Net (Excluding Goodwill) [Abstract] Title Trading Arrangement, Individual Title Equity method investments Other Long-Term Investments Beginning balance Ending balance Unrecognized Tax Benefits Internal Revenue Service (IRS) Internal Revenue Service (IRS) [Member] COVID-19 antibodies COVID-19 Antibodies COVID-19 Antibodies [Member] COVID-19 Antibodies City Area Code City Area Code BioMarin Pharmaceutical Inc. BioMarin Pharmaceutical Inc [Member] BioMarin Pharmaceutical Inc Current Liabilities Liabilities, Current [Abstract] Auditor Location Auditor Location Fair value of securities in an unrealized gain position Debt Securities, Available-for-sale, Unrealized Gain Position Debt Securities, Available-for-sale, Unrealized Gain Position Other noncurrent liabilities Business Combination, Contingent Consideration, Liability Schedule of Additional Stock-Based Compensation Disclosures Schedule of Additional Stock-Based Compensation Disclosures [Table Text Block] Schedule of Additional Stock-Based Compensation Disclosures [Table Text Block] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Audit Information [Abstract] Audit Information [Abstract] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Purchases of short-term investments Payments to Acquire Short-Term Investments Stockholders' Equity Note [Abstract] Stockholders' Equity Note [Abstract] Line of credit facility, remaining borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Purchases of common stock Payments for Repurchase of Common Stock Rest of world Rest Of World [Member] Rest Of World Document Information [Line Items] Document Information [Line Items] Earnings of foreign subsidiaries Deferred Tax Liabilities, Undistributed Foreign Earnings Long-term debt (Note 11) Long-term debt Long-Term Debt, Excluding Current Maturities Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] U.S. and Puerto Rico UNITED STATES And PUERTO RICO [Member] UNITED STATES And PUERTO RICO [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Earnings per share: Earnings Per Share [Abstract] Emgality Patent Litigation Emgality Patent Litigation [Member] Emgality Patent Litigation [Member] Equity [Abstract] Equity [Abstract] Retained earnings Retained Earnings (Accumulated Deficit) Schedule of Amounts Recognized in Other Comprehensive Loss Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Akouos Acquisition Akouos Acquisition [Member] Akouos Acquisition [Member] Class of Stock [Domain] Class of Stock [Domain] Inventories—(increase) decrease Increase (Decrease) in Inventories Sell Euro Sell Euro [Member] Sell Euro [Member] Changes related to the impact of foreign currency translation Unrecognized Tax Benefits, Decrease Resulting from Foreign Currency Translation Schedule of Debt Schedule of Debt [Table Text Block] 1.625% Notes due 2026 1.625% Notes Due June 2, 2026 [Member] 1.625% Notes Due June 2, 2026 [Member] 2026 Long-Term Debt, Maturity, Year Two Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Equity Awards Adjustments Equity Awards Adjustments [Member] Total Operating Lease, Liability Orforglipron Orforglipron [Member] Orforglipron Underlying Securities Award Underlying Securities Amount Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Table] Performance Shares Performance Shares [Member] Weighted-average assumptions used to determine net periodic benefit costs: Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract] Cash dividends declared Dividends, Common Stock, Cash Amendment Flag Amendment Flag Short-term commercial paper borrowings Short-term commercial paper borrowings Commercial Paper Carrying Amount Reported Value Measurement [Member] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Other-Net, (Income) Expense Other Income and Other Expense Disclosure [Text Block] Actual return on plan assets Defined Benefit Plan, Plan Assets, Increase (Decrease) for Actual Return (Loss) Borrowings Debt Disclosure [Text Block] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Schedule of Indefinite-lived Intangible Assets other than Goodwill Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Debt instrument, face amount Debt Instrument, Face Amount Other noncurrent liabilities Derivative Liability, Noncurrent Entity Address, Postal Zip Code Entity Address, Postal Zip Code Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Advertising expense Advertising Expense Forward-starting interest rate swaps Interest Rate Swap [Member] Land Land Number of sites jointly and severally liable for cleanup (fewer than) Loss Contingency, Number Of Sites Jointly And Severally Liable For Cleanup Loss Contingency, Number Of Sites Jointly And Severally Liable For Cleanup Revenue, performance obligation, sales returns, average inventory level (or less) Revenue, Performance Obligation, Sales Returns, Average Inventory Level Revenue, Performance Obligation, Sales Returns, Average Inventory Level 0.500% Notes due 2033 0.50% euro denominated notes due 2033 .5000% Euro Denominated Notes Due 2033 [Member] .5000% Euro Denominated Notes Due 2033 Cash and cash equivalents (Note 7) Cash and Cash Equivalents, at Carrying Value Emgality Emgality [Member] Emgality [Member] Impairment of intangible assets, indefinite-lived Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill) Milestone Payments, Development and Regulatory Milestone Payments, Development and Regulatory [Member] Milestone Payments, Development and Regulatory [Member] Other investing activities, net Payments for (Proceeds from) Other Investing Activities Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Auditor Name Auditor Name 1.700% Notes due 2049 1.700% Notes due 2049 [Member] 1.700% Notes due 2049 [Member] Maturity Date 2024 Maturity Date 2024 [Member] Maturity Date 2024 Raw materials and supplies Inventory, Raw Materials, Gross Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Sales rebates and discounts Sales rebates and discounts Sales rebates and discounts Estimated useful life Property, Plant and Equipment, Useful Life Fair Value Measurement [Domain] Fair Value Measurement [Domain] Total Derivative Instruments, Gain (Loss) Recognized Derivative Instruments, Gain (Loss) Recognized Cash acquired Cash Acquired from Acquisition Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Other securities, noncurrent investments Other Equity Securities [Member] Other Equity Securities [Member] Designated as Hedging Instrument Designated as Hedging Instrument [Member] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Foreign currency exchange rate changes and other adjustments Defined Benefit Plan, Benefit Obligation, Foreign Currency Translation Gain (Loss) Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Equipment Machinery and Equipment, Gross Shares used in calculation of earnings per share: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Projected benefit obligation Defined Benefit Plan, Pension Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation Total assets Total assets Assets Cost of sales Cost of Goods and Services Sold Advertising Expenses Advertising Cost [Policy Text Block] Shares held in employee trust (in shares) Common Stock, Shares Held in Employee Trust, Shares Other noncurrent liabilities Other Liabilities, Noncurrent Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Commitments and Contingencies (Note 16) Commitments and Contingencies Share-based Compensation, Option and Incentive Plans Share-Based Payment Arrangement [Policy Text Block] Schedule of Effective Income Tax Rate Reconciliation Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Acquisitions Asset Acquisition [Text Block] Termination Date Trading Arrangement Termination Date Employee benefit trust Employee benefit trust Common Stock, Shares Held in Employee Trust Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Mortgage-backed securities Collateralized Mortgage-Backed Securities [Member] 2026 Lessee, Operating Lease, Liability, to be Paid, Year Two 2025 Long-Term Debt, Maturity, Year One Senior Notes Due 2026, 2033, 2053 And 2063 Senior Notes Due 2026, 2033, 2053 And 2063 [Member] Senior Notes Due 2026, 2033, 2053 And 2063 5.100% notes due 2064 5.1% Notes Due 2064 [Member] 5.1% Notes Due 2064 Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] 1-5 Years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five Schedule of Recognized Identified Assets Acquired and Liabilities Assumed Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Debt Instrument [Axis] Debt Instrument [Axis] 3.375% notes due 2029 3.375% Notes Due 2029 [Member] 3.375% Notes Due 2029 Net income Net income Net Income (Loss) Attributable to Parent Trading Arrangement: Trading Arrangement [Axis] Schedule of Fair Value, by Balance Sheet Grouping Fair Value, by Balance Sheet Grouping [Table Text Block] Advertising expense, percentage of revenue Advertising Expense, Percentage Of Revenue Advertising Expense, Percentage Of Revenue 2030 - 2034 Defined Benefit Plan, Expected Future Benefit Payment, after Year Five for Next Five Years Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Schedule of Allocation of Plan Assets Schedule of Allocation of Plan Assets [Table Text Block] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Entity File Number Entity File Number Schedule of Assumptions Used Defined Benefit Plan, Assumptions [Table Text Block] Noncontrolling Interest Noncontrolling Interest [Member] Income Statement [Abstract] Income Statement [Abstract] Entity Address, Address Line One Entity Address, Address Line One Federal Current Federal Tax Expense (Benefit) Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Name Forgone Recovery, Individual Name Weighted-average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Change in deferred income taxes Increase (Decrease) in Deferred Income Taxes Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Roche Roche [Member] Roche [Member] Deferred tax liabilities: Components of Deferred Tax Liabilities [Abstract] Schedule of Expected Benefit Payments Schedule of Expected Benefit Payments [Table Text Block] Buildings Buildings and Improvements, Gross Reductions for tax positions of prior years Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Shares expected to be issued (in shares) Share Based Compensation Arrangement by Share-based Payment Award, Expected Shares To Be Issued The number of shares expected to be issued in the next twelve months under the plan. Retirement of treasury shares Treasury Stock, Retired, Cost Method, Amount Statement [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Buy Euro Sell USD Buy Euro Sell Us Dollar [Member] Foreign Currency Forward Commitment to Buy euro Sell US dollar Maturity Date 2027 Maturity Date, 2027 [Member] Maturity Date, 2027 PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Adjustment to Compensation: Adjustment to Compensation [Axis] Accounts Receivable Accounts Receivable [Member] 4.7% notes due 2033 4.7% Notes Due 2033 [Member] 4.7% Notes Due 2033 Litigation Case Type [Domain] Litigation Case [Domain] Accumulated other comprehensive loss (Note 17) Accumulated Other Comprehensive Income (Loss), Net of Tax Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Mounjaro Mounjaro [Member] Mounjaro Document Information [Table] Document Information [Table] Total equity Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Property and equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Cardiometabolic Health Cardiometabolic Health [Member] Cardiometabolic Health Plan assets, target allocation Defined Benefit Plan, Plan Assets, Target Allocation, Percentage 4.900% Notes Due 2032 4.900% Notes Due in 2032 [Member] 4.900% Notes Due in 2032 Name Awards Close in Time to MNPI Disclosures, Individual Name Revenue Benchmark Revenue Benchmark [Member] Zyprexa® Zyprexa [Member] Zyprexa [Member] Entity Filer Category Entity Filer Category Loss Contingencies [Line Items] Loss Contingencies [Line Items] Other noncurrent assets Derivative Asset, Noncurrent Work in process Inventory, Work in Process, Gross Statistical Measurement [Domain] Statistical Measurement [Domain] Expenditures for long-lived assets Segment, Expenditure, Addition to Long-Lived Assets Unrealized gross losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Schedule of Impact of Leases to Consolidated Condensed Financial Statements Lease, Cost [Table Text Block] Olanzapine Portfolio Olanzapine Portfolio [Member] Olanzapine Portfolio Beam Therapeutics Inc. Beam Therapeutics, Inc. [Member] Beam Therapeutics, Inc. Other current liabilities Other Liabilities, Current Unrecognized tax benefits that would impact effective tax rate Unrecognized Tax Benefits that Would Impact Effective Tax Rate 0.45% Swiss franc denominated notes due 2028 0.45% Swiss Franc Denominated Notes Due 2028 [Member] 0.45% Swiss Franc Denominated Notes Due 2028 Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] All Trading Arrangements All Trading Arrangements [Member] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Award vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Tax credit carryforward Tax Credit Carryforward, Amount Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] 5.55% notes due 2037 5.55% Notes Due 2037 [Member] 5.55% Notes Due 2037 Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Derivative [Line Items] Derivative [Line Items] Common Stock (no par value) Common Class A [Member] Pay vs Performance Disclosure [Line Items] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Derivative [Table] Derivative [Table] Cash flow hedges: Cash Flow Hedge [Abstract] Cash Flow Hedge [Abstract] Restructuring and Related Activities [Abstract] Restructuring and Related Activities [Abstract] Other Performance Measure, Amount Other Performance Measure, Amount Rate of compensation increase Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Rate of Compensation Increase 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Three Leases Lessee, Operating Leases [Text Block] Change in net unrealized gains (losses) on available-for-sale securities OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] Weighted average interest rate Short-Term Debt, Weighted Average Interest Rate, at Point in Time Lease expense Operating Lease, Cost Other receivables Other Receivables, Net, Current 4.95% notes due 2063 4.95% Notes Due 2063 [Member] 4.95% Notes Due 2063 Number of shares available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant 4.500% notes due 2029 4.5% Notes Due 2029 [Member] 4.5% Notes Due 2029 Operating lease liabilities, noncurrent portion Operating Lease, Liability, Noncurrent Benefits paid Defined Benefit Plan, Benefit Obligation, Benefits Paid Cash flow hedges Cash Flow Hedging [Member] Service cost Service cost Defined Benefit Plan, Service Cost Entity Tax Identification Number Entity Tax Identification Number 6.77% notes due 2036 6.77% Notes Due 2036 [Member] 6.77% Notes Due 2036 Marketable equity securities Defined Benefit Plan, Equity Securities [Member] Intangible Asset, Finite-Lived [Table] Intangible Asset, Finite-Lived [Table] Summary of Long-term Notes Schedule of Long-Term Debt Instruments [Table Text Block] Additions for tax positions of prior years Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions 1.70% euro denominated notes due 2049 1.7% Euro-denominated Notes Due 2049 [Member] 1.7% Euro-deonominated Notes Due 2049 [Member] Purchase of treasury shares (in shares) Treasury Stock, Shares, Acquired Retirement Plan Type [Axis] Retirement Plan Type [Axis] Foreign Deferred Foreign Income Tax Expense (Benefit) Rate of compensation increase Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Rate of Compensation Increase Common Stock in Treasury Treasury Stock, Common [Member] Schedule of Derivative Instruments Schedule of Derivative Instruments [Table Text Block] Deferred tax assets: Deferred Tax Assets, Net [Abstract] Buy USD Sell Euro Buy USD Sell Euro [Member] Buy USD Sell Euro [Member] Damages awarded, value Loss Contingency, Damages Awarded, Value Equity Components [Axis] Equity Components [Axis] Other current assets Other Assets, Current Research and Development Expense Research and Development Expense, Policy [Policy Text Block] Total Debt Securities, Available-for-Sale Derivative asset, notional amount Derivative Asset, Notional Amount Sales rebates and discounts Deferred Tax Assets, Sales Rebates And Discounts Deferred Tax Assets, Sales Rebates And Discounts Unrecognized net actuarial loss Defined Benefit Plan, Accumulated Other Comprehensive Income (Loss), Gain (Loss), before Tax Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Other comprehensive income (loss): Other Comprehensive Income (Loss), before Tax [Abstract] 0.625% euro denominated notes due 2031 .625% Euro-denominated Notes Due 2031 [Member] .625% Euro-deonominated Notes Due 2031 [Member] Marketed products Developed Technology Rights [Member] Geographical [Axis] Geographical [Axis] Deferred tax assets, net Deferred Tax Assets, Net 2029 Lessee, Operating Lease, Liability, to be Paid, Year Five Change in net unrealized gains (losses) on cash flow hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax 3.1% notes due 2027 3.1% Notes Due 2027 [Member] 3.1% Notes Due 2027 Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Schedule of Equity [Table] Subsidiary or Equity Method Investee, Sale of Stock [Table] Other current liabilities Business Combination, Contingent Consideration, Liability, Current Other neuroscience Other Neuroscience [Member] Other Neuroscience [Member] Issuance of stock under employee stock plans, net (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Long-term income taxes payable (Note 14) Accrued Income Taxes, Noncurrent Unrecognized prior service (benefit) cost Defined Benefit Plan, Accumulated Other Comprehensive (Income) Loss, Prior Service Cost (Credit), before Tax 5.200% notes due 2064 5.2% Notes Due 2064 [Member] 5.2% Notes Due 2064 Fair value of securities in an unrealized loss position Debt Securities, Available-for-Sale, Unrealized Loss Position Total compensation cost not yet recognized Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Actuarial gain (loss) arising during period Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss) Arising During Period, before Tax Foreign Current Foreign Tax Expense (Benefit) Current Assets Assets, Current [Abstract] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Investment Fair Value of Financial Instruments, Policy [Policy Text Block] 2.50% notes due 2060 2.5% Notes Due 2060 [Member] 2.5% Notes Due 2060 Revenue, performance obligation, sales rebate payment period (up to) Revenue, Performance Obligation, Sales Rebate Payment Period Revenue, Performance Obligation, Sales Rebate Payment Period Beginning balance (in shares) Ending balance (in shares) Treasury Stock, Common, Shares Effect from interest rate contracts Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Product and Service [Domain] Product and Service [Domain] Schedule of Effective Portion of Risk-Management Instruments that was Recognized in Other Comprehensive Income (Loss), Net Investment Hedges Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block] Other assets and liabilities, net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets (Liabilities), Net Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets (Liabilities), Net Security Exchange Name Security Exchange Name Reclassification out of Accumulated Other Comprehensive Income Reclassification out of Accumulated Other Comprehensive Income [Member] Number of patents Loss Contingency, Number Of Patents Loss Contingency, Number Of Patents State Current State and Local Tax Expense (Benefit) Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Summary of the Fair Value of Available-for-Sale Securities in an Unrealized Gain or Loss Position Unrealized Gain (Loss) on Investments [Table Text Block] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Proceeds from sale of product rights Proceeds from Sale of Intangible Assets Benefit (expense) for income taxes related to other comprehensive income (loss) Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent Common stock, shares, issued (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Issued Mablink Biosciences SAS Mablink Biosciences SAS [Member] Mablink Biosciences SAS Entity [Domain] Entity [Domain] Line of credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Concentration risk, percentage Concentration Risk, Percentage Share-based Compensation Awards, Fair Value Assumptions Used Share-based Compensation Awards, Fair Value Assumptions Used [Table Text Block] Share-based Compensation Awards, Fair Value Assumptions Used [Table Text Block] Asset impairment, restructuring, and other special charges Restructuring Costs and Asset Impairment Charges December 2024 Share Repurchase Program December 2024 Share Repurchase Program [Member] December 2024 Share Repurchase Program Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Early-stage Early-Stage [Member] Early-Stage Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Schedule of Benefit Obligations in Excess of Fair Value of Plan Assets Defined Benefit Plan, Plan with Projected Benefit Obligation in Excess of Plan Assets [Table Text Block] Three Largest Wholesales Three Largest Wholesales [Member] Three Largest Wholesales [Member] Europe Europe [Member] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Abstract] Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Abstract] Cash paid for acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Purchases of intangible assets Deferred Tax Assets, Goodwill and Intangible Assets Derivative liability, notional amount Derivative Liability, Notional Amount Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Entity Voluntary Filers Entity Voluntary Filers Expiration By 2026 Expiration By 2026 [Member] Expiration By 2026 [Member] May 2021 Share Repurchase Program May 2021 Share Repurchase Program [Member] May 2021 Share Repurchase Program Recognized actuarial (gain) loss Defined Benefit Plan, Amortization of Gain (Loss) Interest expense Interest expense Interest Expense, Nonoperating Hedging Designation [Domain] Hedging Designation [Domain] Total deferred tax benefit Deferred Income Tax Expense (Benefit) Effective portion of losses on interest rate contracts reclassified from accumulated other comprehensive loss Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Property and Equipment Property, Plant and Equipment Disclosure [Text Block] Discount rate Defined Benefit Plan, Assumptions Used Calculating Benefit Obligation, Discount Rate Proceeds from sales and maturities of short-term investments Proceeds from Sale of Short-Term Investments Employee Benefit Trust Trust for Benefit of Employees [Member] Equity method investments Equity Method And Other Investments [Member] Equity Method and Other Investments [Member] Short-term borrowings and current maturities of long-term debt (Note 11) Less current portion Debt, Current Other comprehensive income (loss), net of tax (Note 17) Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Accounts receivable, net of allowances of $14.9 (2024) and $14.8 (2023) Accounts Receivable, after Allowance for Credit Loss, Current Other long-term debt Other Notes Payable Revenues from External Customers and Long-Lived Assets [Line Items] Revenues from External Customers and Long-Lived Assets [Line Items] Long-term debt Long-term debt, including current portion Total long-term notes Long-Term Debt Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Fair value of plan assets at beginning of year Fair value of plan assets at end of year Fair value of plan assets Defined Benefit Plan, Plan Assets, Amount Description of derivative activity volume percent Long-Term Debt, Percentage Bearing Fixed Interest, Converted To Floating Rate Long-Term Debt, Percentage Bearing Fixed Interest, Converted To Floating Rate Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration] Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] 5.000% notes due 2054 A5% Notes Due 2054 [Member] A5% Notes Due 2054 Commercial Paper Commercial Paper [Member] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Purchases of in-process research and development Payments to Acquire in Process Research and Development Document Annual Report Document Annual Report Late-stage Late-Stage [Member] Late-Stage Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Indefinite-lived intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) Amortization expense Amortization of Intangible Assets Contract liabilities Contract with Customer, Liability Outside U.S. Non-US [Member] Accounting Policies [Abstract] Accounting Policies [Abstract] Unamortized note discounts Debt Instrument, Unamortized Discount Contingencies Commitments and Contingencies, Policy [Policy Text Block] Variable rate Long-Term Debt, Percentage Bearing Variable Interest, Percentage Rate Acquisitions Business Combination Disclosure [Text Block] Current Fiscal Year End Date Current Fiscal Year End Date Less imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Short-term investments (Note 7) Short-Term Investments PEO Name PEO Name Actuarial losses Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member] Shares issued in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Award Type [Domain] Award Type [Domain] Cash Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Schedule of Cash Payments Relating to Income Taxes and Tax Act Toll Tax Schedule of Additional Income Tax Disclosures [Table Text Block] Schedule of Additional Income Tax Disclosures [Table Text Block] 2.75% notes due 2025 2.75% Notes Due 2025 [Member] 2.75% Notes Due 2025 Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax [Abstract] Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax [Abstract] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Accrued retirement benefits (Note 15) Accrued retirement benefits Liability, Defined Benefit Plan, Noncurrent Deferred tax assets (Note 14) Deferred Income Tax Assets, Net Non-PEO NEO Non-PEO NEO [Member] Finite-lived intangible asset, useful life (in years) Finite-Lived Intangible Asset, Useful Life Other comprehensive income (loss) before reclassifications OCI, before Reclassifications, Net of Tax, Attributable to Parent Additional Paid-in Capital Additional Paid-in Capital [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Add (deduct): Add (Deduct) [Abstract] Add (Deduct) [Abstract] Long-term notes Notes Payable Retirement Benefits Retirement Benefits [Text Block] Brazil BRAZIL Swap Swiss Francs to USD Swap Swiss Francs To U.S. Dollars [Member] Swap Swiss Francs To U.S. Dollars [Member] Other Effective Income Tax Rate Reconciliation, Other Adjustments, Amount Implementation of New Financial Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Class of Stock [Axis] Class of Stock [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Accumulated Amortization Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Name Measure Name Entity Interactive Data Current Entity Interactive Data Current Erbitux Erbitux [Member] Erbitux [Member] Cash payments of income taxes Income Taxes Paid Morphic Holding, Inc. (Morphic) Morphic Holding, Inc [Member] Morphic Holding, Inc Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] China CHINA Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Investments Valued at Net Asset Value Fair Value Measured at Net Asset Value Per Share [Member] Total deferred tax assets Deferred Tax Assets, Net of Valuation Allowance Retiree Health Benefit Plans Postretirement Health Coverage [Member] Retirement benefit plans Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Costs, expenses, and other Cost of sales, operating expenses, and other-net Cost of sales, operating expenses, and other-net Stated interest rate Debt Instrument, Interest Rate, Stated Percentage Settlements Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Capitalized research and development Deferred Tax Asset, In-Process Research and Development Other—net, (income) expense (Note 18) Other–net, (income) expense Nonoperating Income (Expense) Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Auditor Firm ID Auditor Firm ID Valuation allowance release Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount Research and development Research and Development Expense (Excluding Acquired in Process Cost) Number of reportable segments Number of Reportable Segments Total liabilities and equity Liabilities and Equity 1.625% Notes due 2043 1.625% British pound denominated notes due 2043 1.625% British Pound Denominated Notes Due 2043 [Member] 1.625% British Pound Denominated Notes Due 2043 Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Remaining net operating loss, international Deferred Tax Assets, Operating Loss Carryforwards, Foreign International Defined Benefit Plan, Equity Securities, Non-US [Member] Hedging Designation [Axis] Hedging Designation [Axis] Estimated timing of future cash outflows, after one year Accrued Income Taxes, Noncurrent, Estimated Timing Of Future Cash Outflows, After One Year Accrued Income Taxes, Noncurrent, Estimated Timing Of Future Cash Outflows, After One Year Other current liabilities Derivative Liability, Current Other cardiometabolic health Other Cardiometabolic Health [Member] Other Cardiometabolic Health Interest income Interest income Investment Income, Interest Dividends paid Payments of Dividends Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Schedule of Maturities of Long-term Debt Schedule of Maturities of Long-Term Debt [Table Text Block] Right-of-use assets obtained in exchange for new operating lease liabilities Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Underlying Security Market Price Change Underlying Security Market Price Change, Percent Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward, Name [Domain] Individual: Individual [Axis] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Inventories (Note 6) Inventories Inventory, Net Product and Service [Axis] Product and Service [Axis] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Statement [Line Items] Statement [Line Items] Other Other Product, Total [Member] Other Product, Total [Member] 4.65% notes due 2044 4.65% Notes Due 2044 [Member] 4.65% Notes Due 2044 Benefits paid Defined Benefit Plan, Plan Assets, Benefits Paid Property, Plant and Equipment Property, Plant and Equipment [Table Text Block] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] 2.25% notes due 2050 2.25% Notes Due 2050 [Member] 2.25% Notes Due 2050 [Member] 5.600% Noted Due 2065 5.600% Noted Due in 2065 [Member] 5.600% Noted Due in 2065 Cash paid, net of cash acquired Business Combination, Consideration Transferred Receivables—(increase) decrease Increase (Decrease) in Accounts and Other Receivables Derivatives Derivatives, Policy [Policy Text Block] Reportable Segment Reportable Segment [Member] Reportable Segment Minimum Minimum [Member] Unamortized debt issuance costs Unamortized Debt Issuance Expense Adoption Date Trading Arrangement Adoption Date 6-10 Years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 Percentage of global investments in plan assets Defined Benefit Plan, Percentage of Global Investments in Plan Assets Percentage description of US defined benefit and other postretirement plan assets as compared to the total global investment balance Schedule of Accumulated Benefit Obligations in Excess of Fair Value of Plan Assets Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets [Table Text Block] Segments [Axis] Segments [Axis] Cyramza Cyramza [Member] Cyramza [Member] 2.125% Notes due 2030 2.125% Notes Due June 3, 2030 [Member] 2.125% Notes Due June 3, 2030 [Member] Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Milestone Payments, Sales-based Milestone Payments, Sales-based [Member] Milestone Payments, Sales-based [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Long-term notes, gross Long-Term Debt, Gross Exercise Price Award Exercise Price Schedule of Deferred Tax Assets and Liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Arrangement Duration Trading Arrangement Duration Other Other Product [Member] Other Product [Member] Schedule of Effective Portion of Risk-Management Instruments that was Recognized in Other Comprehensive Income (Loss), Cash Flow Hedges Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block] Operating lease liabilities Deferred Tax Assets, Operating Lease, Liability Deferred Tax Assets, Operating Lease, Liability Operating loss carryforwards Operating Loss Carryforwards Baqsimi Baqsimi [Member] Baqsimi Leases Lessee, Finance Leases [Text Block] Goodwill and Other Intangibles Goodwill and Intangible Assets Disclosure [Text Block] Change in retirement benefit plans (Note 15) Total other comprehensive income (loss) during period Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax Domestic Tax Jurisdiction Domestic Tax Jurisdiction [Member] Cash paid for acquisitions, net of cash acquired Other Payments to Acquire Businesses Investments (Note 7) Noncurrent investments Long-Term Investments Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Debt instrument, term Debt Instrument, Term Fair value of CVR liability Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Contingent Liability Equity-like funds Equity Funds [Member] 2028 Finite-Lived Intangible Asset, Expected Amortization, Year Four All Individuals All Individuals [Member] Building Building [Member] Long-term income taxes payable, estimated timing of future cash outflows not possible Accrued Income Taxes, Noncurrent, Estimated Timing Of Future Cash Outflows Not Possible Accrued Income Taxes, Noncurrent, Estimated Timing Of Future Cash Outflows Not Possible Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Other, net (income) expense Other (income) expense Other Nonoperating Income (Expense) Foreign currency exchange rate changes and other adjustments Defined Benefit Plan, Plan Assets, Foreign Currency Translation Gain (Loss) Contingent value right, additional price per share (in dollars per share) Business Acquisition, Contingent Value Right, Additional Price Per Share Business Acquisition, Contingent Value Right, Additional Price Per Share Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Other intangibles, net (Note 8) Carrying Amount, Net Intangible Assets, Net (Excluding Goodwill) Effective portion of risk-management instruments that was recognized in other comprehensive income (loss) Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax 3.95% notes due 2047 3.95% Notes Due 2047 [Member] 3.95% Notes Due 2047 Unrealized gross gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax Schedule of Amounts Recognized in Other Comprehensive Income (Loss) Schedule of Amounts Recognized in Other Comprehensive Income (Loss) [Table Text Block] Change in plan assets: Defined Benefit Plan, Change in Fair Value of Plan Assets [Roll Forward] Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract] Other current liabilities Liability, Defined Benefit Plan, Current Changes related to the impact of foreign currency translation Unrecognized Tax Benefits, Increase Resulting from Foreign Currency Translation Inventories Deferred Tax Liabilities, Inventory Emerging markets Fixed Income Funds Emerging Markets [Member] An investment that pools funds from many investors to invest in a combination of underlying investments, primarily fixed income investments in EMERGING MARKETS. Total noncurrent liabilities Liabilities, Noncurrent Net losses on foreign currency exchange contracts not designated as hedging instruments Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments Volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Federal Deferred Federal Income Tax Expense (Benefit) Share Repurchase Program [Domain] Share Repurchase Program [Domain] Contingencies Commitments and Contingencies Disclosure [Text Block] Prepaid employee benefits Deferred Tax Liabilities, Prepaid Expenses Change in benefit obligation: Defined Benefit Plan, Change in Benefit Obligation [Roll Forward] Measure: Measure [Axis] Stock-based compensation Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Additions based on tax positions related to the current year Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Table] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized 2025 Defined Benefit Plan, Expected Future Benefit Payment, Year One Unfunded commitments to invest in venture capital funds Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments Entity Emerging Growth Company Entity Emerging Growth Company Indefinite-lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Expiration Between 2030 and 2044 Expiration Between 2030 and 2044 [Member] Expiration Between 2030 and 2044 2029 Long-Term Debt, Maturity, Year Five Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Accumulated benefit obligation Defined Benefit Plan, Plan with Accumulated Benefit Obligation in Excess of Plan Assets, Accumulated Benefit Obligation Change in Accounting Estimate [Line Items] Change in Accounting Estimate [Line Items] Equity Component [Domain] Equity Component [Domain] Net amount recognized Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position Other immunology Other Immunology [Member] Other Immunology Japan JAPAN Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Entity Shell Company Entity Shell Company Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code 2028 Defined Benefit Plan, Expected Future Benefit Payment, Year Four Emergence Therapeutics AG (Emergence) Emergence Therapeutics [Member] Emergence Therapeutics Statement [Table] Statement [Table] Ireland IRELAND AOCI Attributable to Parent [Abstract] AOCI Attributable to Parent [Abstract] Cash payments for interest on borrowings Interest Paid, Excluding Capitalized Interest, Operating Activities 5.5% notes due 2027 5.5% Notes Due 2027 [Member] 5.5% Notes Due 2027 Quoted Prices in Active Markets for Identical Assets (Level 1) Fair Value, Inputs, Level 1 [Member] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Compensation and benefits Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits Total current assets Assets, Current Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Senior Notes Senior Notes [Member] 2027 Long-Term Debt, Maturity, Year Three Foreign Currency Denominated Debt Foreign Currency Denominated Debt [Member] Foreign Currency Denominated Debt [Member] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Employer contribution Defined Benefit Plan, Plan Assets, Contributions by Employer Acquired IPR&D Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Equity investments without readily determinable fair values Equity Securities without Readily Determinable Fair Value, Amount Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer Change in Accounting Estimate, Type [Domain] Change in Accounting Estimate, Type [Domain] Income Taxes Income Tax Disclosure [Text Block] 2028 Lessee, Operating Lease, Liability, to be Paid, Year Four Acquired In-Process Research and Development (IPR&D) In Process Research and Development, Policy [Policy Text Block] Donald Zakrowski [Member] Donald Zakrowski Retirement of treasury shares (in shares) Treasury Stock, Shares, Retired Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Weighted-average discount rate Operating Lease, Weighted Average Discount Rate, Percent Net change in short-term borrowings Proceeds from (Repayments of) Short-Term Debt Net Cash Provided by (Used for) Financing Activities Net Cash Provided by (Used in) Financing Activities Foreign tax redeterminations Deferred Tax Assets, Foreign Tax Redeterminations Deferred Tax Assets, Foreign Tax Redeterminations Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards [Line Items] Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Entity Registrant Name Entity Registrant Name Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Depreciation and amortization Depreciation, Depletion and Amortization Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] State Deferred State and Local Income Tax Expense (Benefit) Fair Value as of Grant Date Award Grant Date Fair Value International operations, including Puerto Rico Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount Customer Concentration Risk Customer Concentration Risk [Member] Other noncurrent assets Assets for Plan Benefits, Defined Benefit Plan Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Remaining amortization period (in years) Finite-Lived Intangible Assets, Remaining Amortization Period Offsetting Assets [Table] Offsetting Assets [Table] Eli Lilly and Company Shareholders' Equity (Notes 12 and 13) Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Geographical [Domain] Geographical [Domain] Tyvyt Tyvyt TYVYT [Member] TYVYT Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] 4.6% Notes Due 2034 4.6% Notes Due 2034 [Member] 4.6% Notes Due 2034 Current federal tax expense, utilization of net operating loss carryforward Current Federal Tax Expense (Benefit), Utilization Of Net Operating Loss Carryforward Current Federal Tax Expense (Benefit), Utilization Of Net Operating Loss Carryforward Correlative tax adjustments Deferred Tax Assets, Corrective Tax Adjustments Deferred Tax Assets, Corrective Tax Adjustments Restatement Determination Date: Restatement Determination Date [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Title of 12(b) Security Title of 12(b) Security Concentration Risk Type [Axis] Concentration Risk Type [Axis] Common stock—no par value Authorized shares: 3,200,000 Issued shares: 947,903 (2024) and 949,781 (2023) Common Stock, Value, Issued Document Financial Statement Error Correction Flag Document Financial Statement Error Correction [Flag] Financial instruments Deferred Tax Liabilities, Derivatives Expected future employer contributions, next fiscal year Defined Benefit Plan, Expected Future Employer Contributions, Next Fiscal Year Amounts recognized in the consolidated balance sheets consisted of: Defined Benefit Plan, Amounts for Asset (Liability) Recognized in Statement of Financial Position [Abstract] Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Oncology Oncology [Member] Revenue to unaffiliated customers, Oncology Less: Business Combination, Cash Acquired [Abstract] Business Combination, Cash Acquired Shareholder Value Awards Shareholder Value Awards [Member] Shareholder Value Awards are granted to officers and management and are payable in shares of common stock at the end of a 3 yr period. Equity securities Equity Securities, FV-NI, Noncurrent Other Deferred Tax Assets, Other Finite-lived intangible assets: Finite-Lived Intangible Assets [Line Items] Indefinite-lived Intangible Assets [Line Items] Indefinite-Lived Intangible Assets [Line Items] Cash Flows from Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] 2029 Defined Benefit Plan, Expected Future Benefit Payment, Year Five 6.77% Notes due 2036 6.77% Notes Due January 1, 2036 [Member] 6.77% Notes Due January 1, 2036 [Member] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Finished products Inventory, Finished Goods, Gross Maturities on long-term debt Long-Term Debt, Fiscal Year Maturity [Abstract] Total deferred tax liabilities Deferred Tax Liabilities, Gross Basic (in dollars per share) Earnings Per Share, Basic Purchases of property and equipment Payments to Acquire Other Property, Plant, and Equipment Operating cash flows from operating leases Operating Lease, Payments Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Foreign currency-denominated notes, designated as hedge Derivatives used in Net Investment Hedge, Net of Tax Remaining net operating loss, domestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic Acquired in-process research and development Acquired in-process research and development Research and Development Asset Acquired in Transaction Other than Business Combination or Joint Venture Formation, Writeoff Royalty Payments Received Royalty Agreement Terms [Member] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Property, Plant and Equipment Property, Plant and Equipment, Policy [Policy Text Block] Total current liabilities Liabilities, Current Other, net of tax Accumulated Net Gain (Loss) from Cash Flow Hedges and Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member] Accumulated Net Gain (Loss) from Cash Flow Hedges and Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member] Share Repurchase Program [Axis] Share Repurchase Program [Axis] Schedule of Collaborative Arrangements Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block] Concentration Risk, Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] 2025 Finite-Lived Intangible Asset, Expected Amortization, Year One Contingent value right, additional price per share, aggregate amount Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Grants in period (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Schedule of Fair Value Information, Assets Fair Value, Assets Measured on Recurring Basis [Table Text Block] Relative Value Awards Relative Value Awards [Member] Relative Value Awards Collaboration and other revenue Collaboration and Other Revenue [Member] Collaboration and Other Revenue [Member] Business Combinations Business Combinations Policy [Policy Text Block] Discount rate Defined Benefit Plan, Assumptions Used Calculating Net Periodic Benefit Cost, Discount Rate Revenue (Note 2) Revenue Revenues Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Pre launch inventory capitalized Inventory, Capitalized, Gross Inventory, Capitalized, Gross Consideration transferred, number of contingent value rights Business Combination, Consideration Transferred, Number Of Contingent Value Rights Business Combination, Consideration Transferred, Number Of Contingent Value Rights Entity Address, City or Town Entity Address, City or Town Proceeds from issuance of long-term debt Proceeds from Issuance of Long-Term Debt Stock-based compensation expense Share-Based Payment Arrangement, Expense NexPharm Parent HoldCo, LLC and Isopro Holdings, LLC NexPharm Parent HoldCo, LLC and Isopro Holdings, LLC [Member] NexPharm Parent HoldCo, LLC and Isopro Holdings, LLC Humulin Humulin [Member] Humulin [Member] Other Comprehensive Income (Loss) Comprehensive Income (Loss) Note [Text Block] Humalog® Humalog [Member] Humalog [Member] Jardiance Jardiance Jardiance [Member] Jardiance [Member] Loss Contingencies [Table] Loss Contingencies [Table] Weighted-average assumptions used to determine benefit obligation as of December 31: Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract] Business Acquisition [Axis] Business Acquisition [Axis] Schedule of Finite-lived Intangible Assets other than Goodwill Schedule of Finite-Lived Intangible Assets [Table Text Block] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Foreign Tax Jurisdiction Foreign Tax Jurisdiction [Member] Operating lease assets Deferred Tax Liabilities, Leasing Arrangements Revenue Revenue from Contract with Customer [Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Purchase of treasury shares Purchase of treasury shares Treasury Stock, Value, Acquired, Cost Method Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] 2029 Finite-Lived Intangible Asset, Expected Amortization, Year Five Document Period End Date Document Period End Date Research and Development Asset Acquired in Transaction Other than Business Combination or Joint Venture Formation Research and Development Asset Acquired in Transaction Other than Business Combination or Joint Venture Formation [Table Text Block] 5.0% Notes Due 2054 5.0% Notes Due 2054 [Member] 5.0% Notes Due 2054 Buy Japanese Yen Sell US Dollar Buy Japanese Yen Sell US Dollar [Member] Buy Japanese Yen Sell US Dollar Total lease payments Lessee, Operating Lease, Liability, to be Paid Cross-currency interest rate swaps Cross Currency Interest Rate Contract [Member] Insider Trading Arrangements [Line Items] Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Line Items] Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] Buy USD Sell Japanese Yen Buy US dollar Sell Japanese Yen [Member] Buy US dollar Sell Japanese Yen [Member] 2027 Lessee, Operating Lease, Liability, to be Paid, Year Three Other Define Benefit Plan, Other [Member] Define Benefit Plan, Other [Member] Cash value of trust owned insurance contract Other Contract [Member] Total accumulated benefit obligation for our defined benefit pension plans Defined Benefit Plan, Accumulated Benefit Obligation Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration] Impairment, Intangible Asset, Indefinite-Lived (Excluding Goodwill), Statement of Income or Comprehensive Income [Extensible Enumeration] Foreign Exchange Contract Foreign Exchange Contract [Member] Reclassifications Reclassification, Comparability Adjustment [Policy Text Block] Document Transition Report Document Transition Report Schedule of Unrecognized Tax Benefits Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block] Purchases of noncurrent investments Payments to Acquire Other Investments 4.700% notes due 2034 4.7% Notes Due 2034 [Member] 4.7% Notes Due 2034 Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Customer [Domain] Customer [Domain] Entity Current Reporting Status Entity Current Reporting Status Developed markets - repurchase agreements Fixed Income Funds - Repurchased Agreements [Member] Fixed Income Funds - Repurchased Agreements [Member] Retained Earnings Retained Earnings [Member] Asset Acquisition [Domain] Asset Acquisition [Domain] 0.56% Japanese yen denominated notes due 2034 .56% Yen-denominated Notes Due 2034 [Member] .56% Yen-denominated Notes Due 2034 [Member] Amortization of net actuarial (gain) loss included in net income Other Comprehensive Income (Loss), Defined Benefit Plan, Gain (Loss), after Reclassification Adjustment, before Tax Schedule of Revenues from External Customers and Long-Lived Assets [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Foreign currency exchange rate changes and other Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax Increase (Decrease) in Shareholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Executive Category: Executive Category [Axis] Schedule of Components of Income Tax Expense Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Net amount reclassified from accumulated other comprehensive loss Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent Company Selected Measure Name Company Selected Measure Name